Skip to main content

2 Result(s)

within Mubiao Liu Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration

    Aberrant activation of STAT3 signal pathway promotes tumor progression in many solid tumor types, including cervical cancer and endometrial cancer. BBI608, the STAT3 inhibitor had been reported in previous stu...

    **g Chen, Shuting Huang, Huawen Li, Yun Li… in Clinical and Translational Oncology (2023)

  2. No Access

    Article

    Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer in China

    This study aimed to compare the 5-year overall survival (OS) and 5-year DFS disease-free survival (DFS) of abdominal radical hysterectomy (ARH) and radiochemotherapy (R-CT) for stage IIA2 (FIGO 2018) cervical ...

    Junshen He, Donglin Li, ** Shen… in International Journal of Clinical Oncology (2022)